Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Brazil Clear all

310 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20035
20044
20057
200624
200712
200814
200919
201029
201113
201212
201317
201418
20159
201614
201717
201810
20199
20209
20219
202212
202310
202415
20253
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed222
Unknown status29
Recruiting22
Terminated16
Active, not recruiting7
Not yet recruiting6
Withdrawn5
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S37
Eli Lilly and Company33
AstraZeneca24
Hospital de Clinicas de Porto Alegre21
Sanofi18
Takeda12
University of Sao Paulo12
University of Sao Paulo General Hospital12
University of Campinas, Brazil11
Hoffmann-La Roche10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2310
Diabetes Mellitus88
Obesity23
Insulin Resistance19
Glucose Metabolism Disorders16
Renal Insufficiency, Chronic14
Dyslipidemias11
Overweight11
Metabolic Diseases9
Cardiovascular Diseases8

Trials

Showing 1 to 25 of 310. Each trial links to its page on Pharma Observatory.

210 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.